Guillain-Barrè Syndrome

Phillip Anson Low, James G. McLeod

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Guillain-Barrè syndrome (GBS) is a subacute immune-mediated demyelinating neuropathy that may cause profound weakness and respiratory failure. Although the disease affects motor fibers preferentially, paresthesias and pain are common sensory manifestations. Autonomic dysfunction in GBS can affect the sympathetic and parasympathetic nervous systems. Autonomic manifestations comprise a combination of autonomic failure and autonomic overreactivity, the latter most commonly being manifested as sinus tachycardia and systemic hypertension. The core features of GBS are the acute onset of an ascending, predominantly motor polyradiculoneuropathy associated with areflexia and increased cerebrospinal fluid protein. Septic and autonomic complications are the major causes of death in GBS because respiratory failure is usually successfully managed with mechanical ventilation. The mainstay of treatment is supportive for the management of orthostatic hypotension (OH) and bowel and bladder symptoms. Because there is suggestive evidence of an immune-mediated process, treatment with intravenous (IV) immunoglobulin or plasma exchange should be undertaken in patients who have moderate to severe weakness, respiratory compromise, or who continue to worsen.

Original languageEnglish (US)
Title of host publicationPrimer on the Autonomic Nervous System: Second Edition
PublisherElsevier Inc.
Pages332-333
Number of pages2
ISBN (Print)9780080473963, 9780125897624
DOIs
StatePublished - May 5 2004

Fingerprint

Respiratory Insufficiency
Polyradiculoneuropathy
Parasympathetic Nervous System
Sinus Tachycardia
Cerebrospinal Fluid Proteins
Orthostatic Hypotension
Plasma Exchange
Paresthesia
Intravenous Immunoglobulins
Sympathetic Nervous System
Artificial Respiration
Cause of Death
Urinary Bladder
Hypertension
Pain
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)
  • Neuroscience(all)

Cite this

Low, P. A., & McLeod, J. G. (2004). Guillain-Barrè Syndrome. In Primer on the Autonomic Nervous System: Second Edition (pp. 332-333). Elsevier Inc.. https://doi.org/10.1016/B978-012589762-4/50090-6

Guillain-Barrè Syndrome. / Low, Phillip Anson; McLeod, James G.

Primer on the Autonomic Nervous System: Second Edition. Elsevier Inc., 2004. p. 332-333.

Research output: Chapter in Book/Report/Conference proceedingChapter

Low, PA & McLeod, JG 2004, Guillain-Barrè Syndrome. in Primer on the Autonomic Nervous System: Second Edition. Elsevier Inc., pp. 332-333. https://doi.org/10.1016/B978-012589762-4/50090-6
Low PA, McLeod JG. Guillain-Barrè Syndrome. In Primer on the Autonomic Nervous System: Second Edition. Elsevier Inc. 2004. p. 332-333 https://doi.org/10.1016/B978-012589762-4/50090-6
Low, Phillip Anson ; McLeod, James G. / Guillain-Barrè Syndrome. Primer on the Autonomic Nervous System: Second Edition. Elsevier Inc., 2004. pp. 332-333
@inbook{66be7e6e738540e2a9448929c85f806c,
title = "Guillain-Barr{\`e} Syndrome",
abstract = "Guillain-Barr{\`e} syndrome (GBS) is a subacute immune-mediated demyelinating neuropathy that may cause profound weakness and respiratory failure. Although the disease affects motor fibers preferentially, paresthesias and pain are common sensory manifestations. Autonomic dysfunction in GBS can affect the sympathetic and parasympathetic nervous systems. Autonomic manifestations comprise a combination of autonomic failure and autonomic overreactivity, the latter most commonly being manifested as sinus tachycardia and systemic hypertension. The core features of GBS are the acute onset of an ascending, predominantly motor polyradiculoneuropathy associated with areflexia and increased cerebrospinal fluid protein. Septic and autonomic complications are the major causes of death in GBS because respiratory failure is usually successfully managed with mechanical ventilation. The mainstay of treatment is supportive for the management of orthostatic hypotension (OH) and bowel and bladder symptoms. Because there is suggestive evidence of an immune-mediated process, treatment with intravenous (IV) immunoglobulin or plasma exchange should be undertaken in patients who have moderate to severe weakness, respiratory compromise, or who continue to worsen.",
author = "Low, {Phillip Anson} and McLeod, {James G.}",
year = "2004",
month = "5",
day = "5",
doi = "10.1016/B978-012589762-4/50090-6",
language = "English (US)",
isbn = "9780080473963",
pages = "332--333",
booktitle = "Primer on the Autonomic Nervous System: Second Edition",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Guillain-Barrè Syndrome

AU - Low, Phillip Anson

AU - McLeod, James G.

PY - 2004/5/5

Y1 - 2004/5/5

N2 - Guillain-Barrè syndrome (GBS) is a subacute immune-mediated demyelinating neuropathy that may cause profound weakness and respiratory failure. Although the disease affects motor fibers preferentially, paresthesias and pain are common sensory manifestations. Autonomic dysfunction in GBS can affect the sympathetic and parasympathetic nervous systems. Autonomic manifestations comprise a combination of autonomic failure and autonomic overreactivity, the latter most commonly being manifested as sinus tachycardia and systemic hypertension. The core features of GBS are the acute onset of an ascending, predominantly motor polyradiculoneuropathy associated with areflexia and increased cerebrospinal fluid protein. Septic and autonomic complications are the major causes of death in GBS because respiratory failure is usually successfully managed with mechanical ventilation. The mainstay of treatment is supportive for the management of orthostatic hypotension (OH) and bowel and bladder symptoms. Because there is suggestive evidence of an immune-mediated process, treatment with intravenous (IV) immunoglobulin or plasma exchange should be undertaken in patients who have moderate to severe weakness, respiratory compromise, or who continue to worsen.

AB - Guillain-Barrè syndrome (GBS) is a subacute immune-mediated demyelinating neuropathy that may cause profound weakness and respiratory failure. Although the disease affects motor fibers preferentially, paresthesias and pain are common sensory manifestations. Autonomic dysfunction in GBS can affect the sympathetic and parasympathetic nervous systems. Autonomic manifestations comprise a combination of autonomic failure and autonomic overreactivity, the latter most commonly being manifested as sinus tachycardia and systemic hypertension. The core features of GBS are the acute onset of an ascending, predominantly motor polyradiculoneuropathy associated with areflexia and increased cerebrospinal fluid protein. Septic and autonomic complications are the major causes of death in GBS because respiratory failure is usually successfully managed with mechanical ventilation. The mainstay of treatment is supportive for the management of orthostatic hypotension (OH) and bowel and bladder symptoms. Because there is suggestive evidence of an immune-mediated process, treatment with intravenous (IV) immunoglobulin or plasma exchange should be undertaken in patients who have moderate to severe weakness, respiratory compromise, or who continue to worsen.

UR - http://www.scopus.com/inward/record.url?scp=84943389037&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943389037&partnerID=8YFLogxK

U2 - 10.1016/B978-012589762-4/50090-6

DO - 10.1016/B978-012589762-4/50090-6

M3 - Chapter

AN - SCOPUS:84943389037

SN - 9780080473963

SN - 9780125897624

SP - 332

EP - 333

BT - Primer on the Autonomic Nervous System: Second Edition

PB - Elsevier Inc.

ER -